Allergy medicine works by interrupting your body’s overreaction to harmless substances like pollen, dust, or pet dander. But “allergy medicine” isn’t one thing. There are several distinct types, each targeting a different step in the allergic process. Understanding what each one does helps explain why some stop sneezing, others unclog your nose, and why your doctor might recommend combining them.
Why Your Body Reacts in the First Place
An allergic reaction starts when your immune system misidentifies something harmless, like ragweed pollen, as a threat. Your body produces antibodies that latch onto immune cells called mast cells. The next time you encounter that allergen, those mast cells release a flood of histamine and other inflammatory chemicals. Histamine binds to receptors throughout your nose, eyes, throat, and skin, triggering the familiar symptoms: sneezing, itching, watery eyes, and a runny nose.
Each type of allergy medicine steps into this chain at a different point. Some block histamine after it’s released. Others prevent the inflammatory cascade from ramping up. And some work to retrain the immune system so it stops overreacting entirely.
Antihistamines: Blocking the Itch and Sneeze Signal
Antihistamines are the most commonly used allergy medicines. They work by competing with histamine for the same receptors on your cells. When the drug occupies those receptor sites, histamine can’t bind and trigger symptoms. This is why antihistamines are most effective at reducing sneezing, itching, runny nose, and watery eyes. They’re less effective at relieving stuffiness, since congestion involves swelling and blood vessel changes that histamine is only partly responsible for.
The major practical difference between antihistamines is whether they make you drowsy. Older, first-generation antihistamines (like diphenhydramine, the active ingredient in Benadryl) cross easily into the brain, where they interfere with histamine’s role in keeping you alert. Brain scans confirm that these drugs readily penetrate the blood-brain barrier and bind to receptors throughout the central nervous system.
Newer, second-generation antihistamines (like cetirizine, loratadine, and fexofenadine) largely avoid the brain. The key reason is a protein called P-glycoprotein, which acts as a pump at the blood-brain barrier, actively pushing these newer drugs back out before they can accumulate. The result is effective allergy relief with minimal drowsiness. These newer antihistamines also tend to bind tightly to receptors and release slowly, which means they last longer per dose, typically 24 hours compared to 4 to 6 hours for the older versions.
Nasal Steroid Sprays: Calming the Inflammation
Nasal corticosteroid sprays (like fluticasone and mometasone) take a broader approach. Instead of blocking one chemical, they suppress the entire inflammatory response in your nasal passages. When you’re exposed to an allergen, your nasal tissue produces a range of inflammatory signaling molecules that recruit more immune cells and amplify swelling. Steroid sprays reduce the production of these signals, dialing down both the early-phase reaction (the immediate sneezing and itching) and the late-phase reaction (the lingering congestion and stuffiness that develops hours later).
This broader mechanism is why current treatment guidelines recommend nasal steroid sprays as the preferred treatment for moderate to severe allergic rhinitis, and why they’re considered more effective than antihistamines alone for nasal congestion. The tradeoff is that they take time to reach full effect, often several days to two weeks of consistent daily use. They aren’t designed for quick relief of a sudden sneezing fit. For the best results, guidelines suggest combining a nasal steroid spray with a nasal antihistamine spray, which covers both the immediate histamine response and the deeper inflammatory process.
Decongestants: Shrinking Swollen Airways
Decongestants do something entirely different from antihistamines or steroids. Your nasal passages contain a dense network of blood vessels, including large, spongy veins deep in the tissue. During an allergic reaction, these vessels swell with blood, physically thickening the lining of your nose and narrowing the airway. That’s what nasal congestion actually is: not mucus blocking your nose (though that contributes), but swollen tissue reducing the space air can flow through.
Decongestants trigger the walls of these blood vessels to contract. The swollen veins shrink, the tissue thins out, and airflow improves. Oral decongestants like pseudoephedrine work indirectly by prompting nerve endings to release norepinephrine, which constricts blood vessels. Nasal spray decongestants like oxymetazoline act directly on the vessel walls for faster, more targeted relief. Because blood flow to the tissue decreases, plasma leakage and nasal secretions also drop, reducing the dripping that comes with congestion.
There’s an important catch with spray decongestants. After about three days of continuous use, the nasal tissue begins to rebound, becoming more swollen than it was before treatment. This condition, called rhinitis medicamentosa, can create a cycle where you need more spray just to breathe normally. Oral decongestants don’t cause this rebound effect but can raise blood pressure and heart rate, making them a poor fit for people with cardiovascular concerns.
Leukotriene Blockers: A Less Common Option
Leukotrienes are another group of inflammatory chemicals your body releases during an allergic reaction, separate from histamine. Leukotriene blockers (the most common being montelukast, sold as Singulair) prevent these chemicals from binding to their receptors, reducing inflammation, mucus production, and swelling. They’re primarily prescribed for asthma but sometimes used for allergic rhinitis.
For hay fever specifically, these medications are now considered a backup option. The FDA added its strongest safety warning to montelukast after reports of serious mood and behavior changes, including agitation, depression, confusion, hallucinations, trouble sleeping, and suicidal thoughts. The FDA now recommends that montelukast only be used for allergic rhinitis in people who don’t respond to or can’t tolerate other allergy medicines. For most people with seasonal allergies, antihistamines and nasal steroid sprays are safer and more effective first choices.
Allergy Immunotherapy: Retraining the Immune System
All the medicines above manage symptoms. Immunotherapy (allergy shots or sublingual drops and tablets) is the only approach that changes the underlying immune response. It works by exposing your body to gradually increasing amounts of the allergen over months to years. This slow exposure shifts how your immune system responds.
Specifically, immunotherapy prompts your body to produce blocking antibodies that intercept the allergen before it can trigger the antibodies responsible for allergic reactions. These blocking antibodies essentially act as decoys, grabbing onto pollen or dust mite proteins before your allergy-driving antibodies can, which prevents the mast cells from activating and releasing histamine in the first place. The immune system also develops a broader tolerance, calming the inflammatory cells that drive chronic allergic inflammation.
The process typically requires three to five years of treatment, but the benefits can last for years after stopping. It’s the only allergy treatment that can potentially eliminate the need for daily medication, and it’s particularly effective for people with allergies to pollen, dust mites, mold, and insect stings.
Why Combining Types Often Works Best
Because each type of allergy medicine targets a different part of the allergic response, combining them often provides better relief than any single medication. A common and effective combination is a daily nasal steroid spray to suppress the overall inflammatory response, paired with a second-generation antihistamine for breakthrough sneezing and itching, and a decongestant used briefly during the worst days of congestion. This layered approach addresses swelling, histamine, and the broader immune overreaction simultaneously, covering gaps that any single medicine would leave open.